Active immunotherapy in spontaneous leukemia of AkR mice
Mathé, G.; Halle-Pannenko, O.; Bourut, C.
Experimental Hematology 1(2): 110-114
1973
ISSN/ISBN: 0301-472X PMID: 4609352 Document Number: 59008
Document emailed within 1 workday
Related Documents
Mathé, G.; Hayat, M.; Amiel, J.L.; Schwarzenberg, L.; Schneider, M.; Pouillart, P.; Cattan, A. 1971: Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man Bollettino dell'Istituto Sieroterapico Milanese 50(4): 251-259Mathé, G.; Pouillart, P.; Schwarzenberg, L. 1973: Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results Annales de Medecine Interne 124(5): 443-448
Bekesi, J.G.; Roboz, J.P. 1981: Prophylactic and therapeutic application of interferon in spontaneous leukemia in AKR mice Texas Reports on Biology and Medicine 41: 614-620
Hiraki, S.; Ranadive, K.J.; Demochowski, L. 1974: An electron microscopic study of spontaneous and experimentally induced leukemia in ICRC mice Cancer Research 34(3): 474-483
Carlson, G.A.; Terres, G. 1978: The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210 Journal of Immunology 121(5): 1752-1759
Hays, E.F.; Margaretten, N.; Swanson, S.K. 1982: Spontaneous leukemia viruses: lymphomagenic ecotropic viruses of AKR mice Journal of the National Cancer Institute 69(5): 1077-1082
Collins, J.K.; Chesebro, B. 1980: Spontaneous cessation of Friend murine leukemia virus production by leukemia cell line Y57: overgrowth by nonproducer cells Journal of the National Cancer Institute 64(5): 1153-1159
Minon, J.M.; Pirenne, H.; Bouillenne, C.; Gaspard, U.; Cusumano, G.; Frère, M.C. 1989: Immunotherapy in patients with habitual spontaneous miscarriage Revue Medicale de Liege 44(4): 149-159
Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Williams, R.; Eddleston, A.L. 1979: Chronic active hepatitis: immunopathogenesis and immunotherapy Israel Journal of Medical Sciences 15(3): 261-275
2014: Modern cancer treatment by active immunotherapy Versicherungsmedizin 66(1): 48-49
Amiel, J.L. 1970: Immunotherapy of leukemia Bruxelles Medical 50(3): 185-194
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Mellstedt, H.åk.; Veelken, H. 2005: Active immunotherapy in patients with hematologic and solid neoplasms Onkologie 28(Suppl 4): 4-8
Modianova, E.A.; Bocharova, O.A.; Ushakov, V.F. 1980: Mechanical properties of the intercellular contacts of hepatocytes of inbred strains of mice and mice predisposed to spontaneous hepatomas Biulleten' Eksperimental'noi Biologii i Meditsiny 89(4): 459-462
Suit, H.D.; Sedlacek, R.S.; Zietman, A. 1988: Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice Cancer Research 48(16): 4525-4528
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11
Mocellin, S. 2005: Priming anticancer active specific immunotherapy with dendritic cells Current Opinion in Investigational Drugs 6(6): 576-581
Neagoe, G.; Stoian, M. 1986: Methods of active immunotherapy and viral oncolysis in some forms of cancer Medecine Interne 24(2): 125-142
Lynn, T.C.; Metzgar, R.S. 1980: Immunotherapy of Friend leukemia with antiserum Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 13(1): 94-104